Tenders/IPR 126128015 - SOQ 22602757 - Pharmaceutical Item / SSS

IPR 126128015 - SOQ 22602757 - Pharmaceutical Item / SSS

Dubai Academic Health Corporation

Published: Nov 12, 2026

Updated: Nov 13, 2026

About This Opportunity

This is a services contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in United Arab Emirates, Middle East & North Africa, this opportunity is open to firms and consortiums.

Published through Dubai eSupply, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, originating from the United Arab Emirates and managed through the dubai_esupply platform, concerns 'Pharmaceutical Item / SSS' under Intellectual Property Rights (IPR) 126128015 and Specification of Quantity (SOQ) 22602757. The contracting authority is seeking the supply of a specific pharmaceutical product or a range of related pharmaceutical items. This procurement is within the healthcare and pharmaceutical sector, requiring suppliers to meet stringent quality and regulatory standards. Bidders are expected to be licensed pharmaceutical distributors or manufacturers with a proven track record in supplying medical goods. Typical requirements for this tender include providing detailed product information, including active ingredients, dosage forms, strengths, and therapeutic indications. Suppliers must demonstrate compliance with Good Manufacturing Practices (GMP), Good Distribution Practices (GDP), and relevant international and local regulatory approvals. Evidence of product registration with the UAE Ministry of Health is likely to be mandatory. The tender will assess the quality and authenticity of the pharmaceutical items, the supplier's technical and financial capabilities, adherence to specifications, and the proposed pricing. Reliability of supply and timely delivery are critical factors for evaluation.

Data provenance

This notice is sourced from Dubai eSupply and was originally published on November 12, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dubai Academic Health Corporation

Dubai Academic Health Corporation has issued 1,754 procurement notices on BidsFactory, including 52 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for United Arab Emirates. Notices are distributed via Dubai eSupply. Most recent publication: November 13, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in United Arab Emirates. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Dubai eSupply to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Dubai Academic Health Corporation in United Arab Emirates. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.